COVID-19: Health Canada’s chief medical advisor outlines use of Pfizer antiviral pill
Health Canada’s Chief Medical Advisor Dr. Surpiya Sharma explained in a press conference on Monday how the newly-approved Pfizer antiviral pill for COVID-19 works. The drug is intended for use as soon as possible after the diagnosis of COVID-19 in a patient and within five days of the start of symptoms.
UP NEXT
NOW PLAYING: other
COVID-19: Health Canada’s chief medical advisor outlines use of Pfizer antiviral pill
Global News
UP NEXT
-
GTA hit by strong winds, rain and hail as storm moves through region
Global News
-
Some B.C. wineries survived the pandemic thanks to local wine lovers
-
After Canada’s ban of Huawei’s 5G technology, what a Chinese retaliation could look like
-
Evidence released in public mischief case of Surrey mayor Doug McCallum
-
Court documents raise questions about future of Surrey mayor
-
Edmonton city councillors react to transit safety report
-
Chinese Cultural Centre gate in Vancouver vandalized
-
Musician says airline smashed prized instrument
-
Vancouver city council mandates additional electric vehicle chargers
-
Governor General Mary Simon makes first official visit to B.C.
-
Jury hears from father, son on 5th day of Métis hunters murder trial
-
NAIT students use education to give back to village school in Peru
-
Huawei 5G ban could be costly for Canadian consumers, smaller telcos
-
Scientists trying to identify origins of Monkeypox cases detected in Canada
-
Royal tour to Canada wraps up amid calls for real action towards reconciliation
-
Emergency room at Alberta Children's Hospital 'extremely busy,' complex mental health needs adding to the issue
